How Are Injectable Drug Delivery Market Players Working To Provide Convenience To Customers?

Injectable Drug Delivery Market Report 2021 - COVID-19 Growth And Change

Injectable Drug Delivery Global Market Report 2021 – COVID-19 Growth And Change

The Business Research Company’s Injectable Drug Delivery Global Market Report 2021 – COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, October 11, 2021 / — Companies in the injectable drug delivery devices are increasingly focusing on the manufacturing of auto injectors. Auto injectors are fully automated, highly customized and reusable injectors that can be used by a patient to perform hundreds of injections. Patients can control the speed of dose delivery to help minimize pain or discomfort during an injection. These devices have the ability to adjust the speed and depth of the automatic injection. For instance, LISA, a reusable auto-injector manufactured by Unilife corporation comes with an array of highly customizable features including Bluetooth LE connectivity, Wi-Fi or 3G connectivity and pre-injection drug warming for target therapies. The injectable drug delivery market is expected to show significant growth in the coming years, due to various technological advancements and new product launches in order to improve the convenience and ease of administration of parenteral therapeutics.

Major players covered in the global injectable drug delivery market are Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Schott AG, Baxter International, Owen Mumford, Mylan N.V., Sanofi, Antares Pharma, Bespak, Ypsomed, Unilife Corporation, Genentech Inc., Alkermes Plc.

Read More On The Global Injectable Drug Delivery Market Report:

The global injectable drug delivery market size is expected to grow from $15.38 billion in 2020 to $17.13 billion in 2021 at a compound annual growth rate (CAGR) of 11.4%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The injectable drug delivery market is expected to reach $25.79 billion in 2025 at a CAGR of 10.8%.

TBRC’s injectable drug delivery devices market report is segmented by type into conventional injectable, pre-filled syringes, auto-injectors, pen-injectors, by application into autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, others, by end user into hospitals and clinics, home healthcare settings, pharmaceutical and biotechnological companies, research laboratories, others.

Injectable Drug Delivery Devices Global Market Report 2021 – By Type (Conventional Injectable, Pre-Filled Syringes, Auto-Injectors, Pen-Injectors), By Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy), By End User (Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories), COVID-19 Growth And Change is one of a series of new reports from The Business Research Company that provides injectable drug delivery market overview, forecast injectable drug delivery market size and growth for the whole market, injectable drug delivery market segments, and geographies, injectable drug delivery market trends, injectable drug delivery market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Injectable Drug Delivery Market Report:

Here Is A List Of Similar Reports By The Business Research Company:

Drug Delivery Devices Market 2021 – By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

Implantable Drug Delivery Devices Global Market Report 2021 – By Product (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bio-absorbable Stents, Intraocular Stents, Infusion Pumps), By Technology (Diffusion, Osmotic, Magnetic), By Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases), COVID-19 Growth And Change

Liposomal Drug Delivery Devices Global Market Report 2021 – By Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B), By Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics), COVID 19 Growth And Change

Interested to know more about The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at

Or get a quick glimpse of our services here:

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Follow us on LinkedIn:
Follow us on Twitter:
Check out our Blog:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Leave a Reply

Your email address will not be published.